Phase 1 Dose Escalation of ArtemiCoffee

Phase 1 Dose Escalation of ArtemiCoffee
Condition:   Ovarian Cancer
Interventions:   Drug: Artemisia annua 450mg;   Drug: Artemisia annua 900mg;   Drug: Artemisia annua 1350mg;   Drug: Artemisia annua 1800mg;   Drug: Artemisia annua – recommended phase II dose
Sponsors:   Jill M Kolesar;   ArtemiLife

Source: View full study details on

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 11, 2022Comments | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine